Free Cash Flow - InterCure Ltd (NASDAQ:INCR) - Alpha Spread
I

InterCure Ltd
NASDAQ:INCR

Watchlist Manager
InterCure Ltd
NASDAQ:INCR
Watchlist
Price: 1.86 USD Market Closed
Market Cap: 84.8m USD
Have any thoughts about
InterCure Ltd?
Write Note

InterCure Ltd
Free Cash Flow

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

InterCure Ltd
Free Cash Flow Peer Comparison

Comparables:
TEVA
RDHL
SLGL
MDWD
R
REKA

Competitive Free Cash Flow Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
I
InterCure Ltd
NASDAQ:INCR
Free Cash Flow
-â‚Ş56.3m
CAGR 3-Years
-63%
CAGR 5-Years
-104%
CAGR 10-Years
-31%
Teva Pharmaceutical Industries Ltd
NYSE:TEVA
Free Cash Flow
$679m
CAGR 3-Years
N/A
CAGR 5-Years
52%
CAGR 10-Years
-14%
Redhill Biopharma Ltd
NASDAQ:RDHL
Free Cash Flow
-$24.2m
CAGR 3-Years
23%
CAGR 5-Years
7%
CAGR 10-Years
-3%
Sol Gel Technologies Ltd
NASDAQ:SLGL
Free Cash Flow
-$17m
CAGR 3-Years
14%
CAGR 5-Years
-32%
CAGR 10-Years
N/A
Mediwound Ltd
NASDAQ:MDWD
Free Cash Flow
-$22.3m
CAGR 3-Years
-47%
CAGR 5-Years
N/A
CAGR 10-Years
-5%
R
Rekah Pharmaceutical Industry Ltd
TASE:REKA
Free Cash Flow
â‚Ş24.5m
CAGR 3-Years
129%
CAGR 5-Years
3%
CAGR 10-Years
40%

See Also

What is InterCure Ltd's Free Cash Flow?
Free Cash Flow
-56.3m ILS

Based on the financial report for Dec 31, 2023, InterCure Ltd's Free Cash Flow amounts to -56.3m ILS.

What is InterCure Ltd's Free Cash Flow growth rate?
Free Cash Flow CAGR 10Y
-31%

The average annual Free Cash Flow growth rates for InterCure Ltd have been -63% over the past three years , -104% over the past five years , and -31% over the past ten years .

Back to Top